Seed-stage investing in consumer and health brands requires a different evaluation framework than seed investing in enterprise software or platform businesses. The founder signals that predict outlier outcomes in consumer differ in meaningful ways from the signals that predict success in SaaS, and investors who apply the same framework across both categories will consistently misidentify the right bets.
At Root Evidence Ventures, we have spent years refining what we look for in the earliest consumer and health founders. We write our first check before revenue in many cases, before a complete team in some cases, and occasionally before a finished product. The evaluation framework that guides these decisions has been developed through hundreds of meetings, dozens of portfolio companies, and the accumulating pattern recognition that comes from tracking early signals against eventual outcomes.
This piece is our attempt to share the framework openly. We believe transparency about how we think creates better founder conversations, better pitches, and ultimately better companies. And frankly, we think the best founders are the ones who are comfortable being evaluated rigorously because they have done the work to be genuinely ready for that rigor.
Signal One: The Specificity of Customer Understanding
The single most predictive signal at the seed stage in consumer and health is the depth and specificity of a founder's understanding of their target customer. Not market research depth — founding team customer intimacy. We are looking for founders who can describe a specific customer archetype with the granularity of someone who has had a hundred real conversations with real customers and has been listening carefully in all of them.
The generic customer description — "health-conscious millennials" or "working mothers aged 25 to 45" — tells us almost nothing. What we want to hear is something like: "Our core early customer is a woman in her early thirties who has already tried two or three products in this category, has some familiarity with the scientific mechanism, buys primarily based on ingredient transparency, and discovers products through recommendations from a specific type of practitioner or influencer community rather than through paid social." That level of specificity signals genuine primary research and genuine empathy.
We follow up on customer descriptions with specific questions: How did you arrive at this understanding? What surprised you most in your customer conversations? What does this customer believe about the category before they discover you? What objections have you heard most frequently? Founders who can answer these questions specifically and consistently are founders who have done the work, and in our experience, this work predicts almost everything else about how they will build the company.
Signal Two: The Relationship Between Problem and Mechanism
Consumer and health companies that create durable value are almost always built on a genuine product insight, not just a distribution insight. We differentiate these two types of founders carefully. A distribution insight founder has identified an underserved customer segment or an underutilized acquisition channel and is bringing a product to market primarily because the path to customer exists. A product insight founder has identified a genuine gap between what customers need at a mechanistic level and what currently exists, and is building a company to close that gap.
Distribution insight companies can be successful, but they are structurally vulnerable to competitors who identify the same channel or segment and compete on price. Product insight companies create defensibility through genuine efficacy — customers who experience real outcomes become brand advocates and have high switching costs because the alternative is accepting worse outcomes.
We evaluate this by asking founders to explain their product at a mechanism level. What specific outcome does this product create for the customer? What is the mechanism by which that outcome is produced? What does the customer experience that proves to them the product is working? Founders who can answer these questions clearly and specifically are almost always building on product insight. Founders who default to market size and distribution strategy often have the distribution insight model, even if they describe it in product language.
Signal Three: The Retention Theory
We ask every seed-stage consumer and health founder the same question: "What is your theory of why customers will keep buying?" The answers to this question are enormously revealing. The weakest answers focus on product quality alone — the product is so good that customers will keep buying because they are satisfied. This is not a theory of retention; it is a hope. The strongest answers articulate a specific mechanism by which repeat purchase becomes a default behavior rather than a conversion event.
In health specifically, the strongest retention theories are built on outcome progression. A product that helps customers progress toward a meaningful health goal creates a category of customer who repurchases not because of brand loyalty but because they are in the middle of a journey they want to complete. This outcome-progression retention is the most powerful in the category because it is driven by the customer's own goals rather than by marketing spend or artificial switching costs.
Strong retention theories also address how the brand relationship deepens over time. What do customers know about the product, the brand, and themselves after six months of use that makes them more valuable to the brand and makes the brand more valuable to them? Founders who have a specific answer to this question are building companies with compounding customer asset value, not just transactional revenue streams.
Signal Four: Evidence Standard Clarity
In consumer health specifically, one of the most important founder signals is how they think about the evidence standard they are setting for themselves and their products. This has both an ethical dimension and a business dimension, and we weigh it heavily in our evaluation.
On the ethical dimension, we will not back founders who are willing to make marketing claims that outpace their product's demonstrated efficacy. This is both a principled position and a practical one — brands that overstate their evidence create regulatory risk and, more importantly, create customers who do not achieve the outcomes they were promised and who therefore churn and generate negative word-of-mouth.
On the business dimension, founders who think clearly about evidence standards are thinking clearly about what it will take to make their product defensible over time. What studies are they planning? What outcome data are they going to collect from customers? How will they use that data in marketing and product development? These questions reveal whether a founder sees their evidence base as a building asset or as a compliance requirement, and the distinction matters enormously for how the company will be built.
Signal Five: Brand vs. Product Differentiation
In consumer markets, there is an ongoing tension between building a brand and building a product. The best consumer companies ultimately build both, but the founding team's primary identity often determines which comes first and which gets the most investment. We look carefully at whether a founder's intuition is primarily brand-driven or product-driven, and we assess whether their category requires one emphasis more than the other.
Health brands tend to require product-first thinking at the seed stage because the customer acquisition story in health is built on efficacy. If the product does not work, no amount of brand investment creates a sustainable business. Consumer lifestyle brands often allow more brand-first thinking because the product's role is partly functional and partly expressive, and the brand's ability to capture and communicate an identity is as important as the product's functional performance.
We look for founders in health who have strong product intuition and are actively developing brand intuition. We look for founders in consumer lifestyle categories who have strong brand intuition and are actively developing a theory of why their product is genuinely better than alternatives. The combination of both is rare and is one of the clearest signals of a founder who will build something truly durable.
Signal Six: How They Talk About Their Competition
The way a founder describes their competitive landscape reveals significant information about the quality of their market analysis and the maturity of their strategic thinking. We have learned to look for three specific things in competitive discussion: accuracy, respect, and differentiation specificity.
Accuracy means that the founder's description of competing products matches our own understanding of those products. Founders who mischaracterize competitors are often doing so to simplify their narrative, and that simplification usually reflects a gap in competitive analysis that will become a strategic vulnerability. Founders who describe competitors accurately, including their strengths, are signaling that they have done the work.
Respect means that the founder takes competition seriously rather than dismissing it. The "we have no real competition" framing is almost always wrong in consumer markets and almost always signals a founder who has not done the primary customer research to understand that their target customers are already solving their problem with something. That something is their competition, even if it does not look exactly like their product.
Differentiation specificity means that the founder can articulate precisely why they win against specific competitors in specific customer scenarios, not just in general. "We are better quality" is not differentiation specificity. "We win against Brand X for customers who have tried Brand X and were unsatisfied with outcome Y because our formulation addresses mechanism Z in a way that Brand X does not" is differentiation specificity.
Key Takeaways
- The most predictive seed-stage signal in consumer is the depth and specificity of a founder's customer understanding, evidenced through primary research.
- Product insight founders build on genuine efficacy gaps and create defensibility through outcomes. Distribution insight founders are more vulnerable to competitive displacement.
- Retention theory matters at the seed stage. The strongest retention stories in health are built on outcome progression, not product quality alone.
- Evidence standard clarity is both an ethical and a business signal in consumer health. Founders who build their evidence base deliberately create compounding competitive advantages.
- Brand-versus-product intuition should match the category. Health requires product-first thinking; consumer lifestyle allows more brand-first thinking.
Conclusion
The signals we look for at Root Evidence Ventures are not a checklist that any founder can pass by preparing the right answers. They are signals that emerge from genuine work — the customer research, the product iteration, the thinking about retention and evidence and competition that represents a founder who has been genuinely building rather than just pitching. That work shows up in how founders talk, in the specificity of their answers, and in the texture of the questions they ask us.
If you are a founder who has been doing this work in consumer DTC or health, we would genuinely like to meet you. You can find us through our contact page. Come prepared to tell us who your customer is with specificity, and the rest of the conversation will take care of itself.